Outcomes of Ibrutinib Therapy Given after Prior Venetoclax Therapy in Ibrutinib-Naive Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
- Resource Type
- Journal
- Source
BLOOD ; NOV 29 2018, 132 4p. Supplement: 1- Subject
- Language
- English
- ISSN
- 15280020